Results 221 to 230 of about 288,150 (296)

Current Challenges and Future Directions in the Multimodal Management of Gastric Cancer with Peritoneal Metastases. [PDF]

Cancers (Basel)
Cossu A, Puccetti F, Rosati R, Elmore U.
europepmc   +1 more source

Paraurethral Endometrioid Carcinoma Arising From Ectopic Endometriosis: A Case Report

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Malignant transformation of endometriosis is rare and most commonly involves the ovary; transformation from paraurethral endometriosis is exceedingly rare. Case Presentation A 73‐year‐old postmenopausal woman with prior ovarian endometrioma presented with dysuria and voiding difficulty.
Keita Ogasawara, Takashi Tsuyukubo, Mizuki Hisano, Hiromitsu Fujisawa, Shigekatsu Maekawa, Mitsugu Kanehira, Mitsumasa Osakabe, Naoki Yanagawa, Hiroaki Itamochi, Wataru Obara   +9 more
wiley   +1 more source

Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Urachal carcinoma is a rare and aggressive malignancy with no established systemic therapy after platinum failure. Evidence for immune checkpoint inhibitors (ICIs) remains limited, particularly in tumors without established favorable biomarkers such as microsatellite instability‐high status or high tumor mutational burden.
Fumihiro Ito, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Takashi Fujita   +4 more
wiley   +1 more source

Grade 1 Hepatic Neuroendocrine Tumor with Peritoneal Metastases: Case Report - Diagnostic Reasoning and Management Challenges. [PDF]

Case Rep Gastroenterol
Tsai TL, Guo JW, Lin CL, Lien HH.
europepmc   +1 more source

Multidisciplinary Treatment of Abdominal Wall Recurrence After Bladder Perforation During Transurethral Resection of a Bladder Tumor

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Sarcomatoid urothelial carcinoma is a rare, highly aggressive bladder cancer subtype. We report the first case of abdominal wall implantation of sarcomatoid urothelial carcinoma after bladder perforation during transurethral resection of a bladder tumor, followed by recurrence at the open repair site requiring further resection ...
Tomoki Kimura, Takaharu Hamada, Shota Umezawa, Gaku Okumura, Shu Gozu, Madoka Kataoka, Shugo Yajima, Yasukazu Nakanishi, Hitoshi Masuda   +8 more
wiley   +1 more source

Textbook oncologic outcomes after cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a single-centre cohort analysis. [PDF]

Pleura Peritoneum
Brindl N, Castagna A, Welsch T, Al-Saeedi M, Schneider M, Büchler M, Brandl A.   +6 more
europepmc   +1 more source

Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
Our graphical abstract summarizes a novel immunosuppressive axis in HCC whereby tumor cell‐derived SCF recruits and activates mast cells, leading to CCL17 secretion and subsequent recruitment of CCR4+ regulatory T cells. This cascade suppresses CD8+ T cell‐mediated antitumor immunity and promotes resistance to anti‐PD‐1 therapy.
Shuai Yang, Chuang Yang
wiley   +1 more source

Gastrointestinal CancerEmerging treatment modalities for gastric cancer with peritoneal metastases: a systematic review. [PDF]

Oncologist
Tops-Welten MW, Galanos LJK, Creemers GJ, Luyer MDP, De Hingh IHJT, van Hellemond IEG.   +5 more
europepmc   +1 more source

The Efferocytosis‐Driven Macrophage Polarization: A Concerto in the Tumor Immunosuppressive Microenvironment

MedComm, Volume 7, Issue 11, November 2026.
Efferocytosis is a key process for macrophages to clear apoptotic cells, which undergoes the “ Find Me” chemotaxis signal stage, the “eat me” phagocytosis recognition stage and the “digest me” digestion stage in turn. During the aforementioned three stages, various signaling molecules released by apoptotic cells can promote the phenotypic polarization ...
Qiuping Chen, Chunzhi Wu, Changquan Huang, Hang Zhou   +3 more
wiley   +1 more source

Liquid Biopsy: Past, Present, and Future

MedComm, Volume 7, Issue 11, November 2026.
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Jiachen Liu, Dianjie Zeng, Keran Zhao, Yuxi Wang, Huijie Hu, Fei Deng, Yinhuai Wang, Liya Sun, Liangmin Fu   +8 more
wiley   +1 more source